Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TEMPUS GEMINI NSCLC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Non-Small Cell Lung Cancer (NSCLC)

NCT05236114 is registered in ClinicalTrials.gov with Tempus AI as lead sponsor.

NCT NCT05236114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05236114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TEMPUS GEMINI NSCLC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Non-Small Cell Lung Cancer (NSCLC)
Lead sponsor
Tempus AI
Phase
Observational
Overall status
Recruiting
Start date
June 22, 2022
Completion date
June 30, 2029
Enrollment
1,200 (estimated)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer